title: Infections in inflammatory bowel disease.
abstract: Patients with inflammatory bowel disease constitute a population with a special predisposition to develop bacterial, viral and fungal infections. Iatrogenic immunosuppression, frequent contact with healthcare facilities and surgical interventions are some of the risk factors that explain why these infections are one of the main causes of morbi-mortality in this disease. Some of these infections follow a subtle and paucisymptomatic evolution; their diagnosis and management may become a real challenge for the attending physician if their screening is not systematized or they are not considered in the differential diagnosis. The objective of this review is to provide an update from a practical and concise perspective on the knowledge regarding the epidemiology, prevention, diagnosis and treatment of the most common infections.
authors.affiliation: Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Madrid, España. Electronic address: e_rodriguez_de_santiago@hotmail.com.
authors.forename: Enrique
authors.initials: E
authors.lastname: Rodríguez de Santiago
authors.affiliation: Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Madrid, España; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad de Alcalá de Henares, Alcalá de Henares, Madrid, España.
authors.forename: Agustín
authors.initials: A
authors.lastname: Albillos Martínez
authors.affiliation: Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Madrid, España; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad de Alcalá de Henares, Alcalá de Henares, Madrid, España.
authors.forename: Antonio
authors.initials: A
authors.lastname: López-Sanromán
mesh_terms: D001424:Bacterial Infections / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D009181:Mycoses / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D012307:Risk Factors; D014777:Virus Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy
chemical_list: D007166:Immunosuppressive Agents
keywords: Colitis ulcerosa; Crohn's disease; Enfermedad de Crohn; Enfermedad inflamatoria intestinal; Immunosuppression; Infecciones; Infections; Inflammatory bowel disease; Inmunosupresión; Ulcerative colitis